A RANDOMIZED TRIAL OF TEST RESULT SEQUENCING IN PATIENTS WITH SUSPECTED MULTIPLE-SCLEROSIS

被引:12
|
作者
OCONNOR, P
TANSEY, C
KUCHARCZYK, W
DETSKY, AS
机构
[1] UNIV TORONTO,ROCHESTER TORONTO MRI STUDY GRP,TORONTO M5S 1A1,ONTARIO,CANADA
[2] UNIV TORONTO,MS CLIN,TORONTO M5S 1A1,ONTARIO,CANADA
[3] UNIV TORONTO,DIV NEUROL,TORONTO M5S 1A1,ONTARIO,CANADA
[4] UNIV TORONTO,DIV GEN INTERNAL MED,TORONTO M5S 1A1,ONTARIO,CANADA
[5] UNIV TORONTO,DIV CLIN EPIDEMIOL,TORONTO M5S 1A1,ONTARIO,CANADA
[6] UNIV TORONTO,DEPT RADIOL,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.1001/archneur.1994.00540130079014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Methods: We performed a randomized trial of the incremental impact of high-volume contrast computed tomographic scan of the brain plus trimodal evoked potentials vs magnetic resonance imaging of the brain on neurologists' diagnostic labeling of patients with suspected multiple sclerosis (MS). Two hundred and four patients with suspected MS (clinically possible 59% or probable 41%-McAlpine criteria) were assessed by two neurologists. Patients were diagnostically categorized after reviewing the results of the tests presented in random order. Results: Most of the change in diagnostic Categorization occurred after presenting the first test result irrespective of result sequence (chi2=0.01, P=.99). The diagnoses became more definitive when all test results were available (P<.001). Magnetic resonance imaging and evoked potential were suggestive of MS equally frequently (chi2=0.57, P=.45). Conclusion: In suspected MS, there is no difference in diagnostic effect between brain magnetic resonance image scanning and computed tomography plus trimodal evoked potentials.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [1] A RANDOMIZED TRIAL OF DIAGNOSTIC-TEST SEQUENCING IN MULTIPLE-SCLEROSIS
    OCONNOR, PO
    DETSKY, AS
    KUCHARCZYK, W
    TANSEY, C
    [J]. MEDICAL DECISION MAKING, 1991, 11 (04) : 324 - 324
  • [2] A RANDOMIZED TRIAL OF DIAGNOSTIC-TEST SEQUENCING IN MULTIPLE-SCLEROSIS
    OCONNOR, P
    DETSKY, AS
    KUCHARCZYK, W
    TANSEY, C
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A415 - A415
  • [3] THE ACCURACY OF MRI IN PATIENTS WITH SUSPECTED MULTIPLE-SCLEROSIS
    MUSHLIN, AI
    PHELPS, CE
    HALL, WJ
    KIDO, D
    MOONEY, C
    GIANG, D
    GROW, V
    [J]. MEDICAL DECISION MAKING, 1991, 11 (04) : 328 - 328
  • [4] THE VALUE OF DIAGNOSTIC INFORMATION TO PATIENTS WITH SUSPECTED MULTIPLE-SCLEROSIS
    MUSHLIN, AI
    MOONEY, C
    GROW, V
    PHELPS, CE
    [J]. ARCHIVES OF NEUROLOGY, 1994, 51 (01) : 67 - 72
  • [5] SELECTION OF ELECTROPHYSIOLOGICAL TESTS IN PATIENTS WITH SUSPECTED MULTIPLE-SCLEROSIS
    TOGLIA, J
    [J]. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, (03): : 89 - 95
  • [6] CLINICAL CONTROLLED RANDOMIZED TRIAL OF AZATHIOPRINE IN MULTIPLE-SCLEROSIS
    GHEZZI, A
    DIFALCO, M
    LOCATELLI, C
    ZAFFARONI, M
    CAPUTO, D
    MARFORIO, S
    CAZZULLO, CL
    [J]. RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 345 - 346
  • [7] DIAGNOSTIC MEASURES IN SUSPECTED MULTIPLE-SCLEROSIS
    KUNZE, K
    HARTARD, C
    SPITZER, K
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (11) : 424 - 426
  • [8] BIOFEEDBACK TREATMENT OF BLADDER DYSFUNCTION IN MULTIPLE-SCLEROSIS - A RANDOMIZED TRIAL
    KLARSKOV, P
    HEELY, E
    NYHOLDT, I
    ROTTENSTEN, K
    NORDENBO, A
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1994, : 61 - 65